Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

THERMO FISHER SCIENTIFIC

(TMO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

SVB Leerink Adjusts Thermo Fisher Scientific's Price Target to $685 from $675, Maintains Outperform Rating

10/28/2021 | 10:43am EST


ę MT Newswires 2021
All news about THERMO FISHER SCIENTIFIC
04:06pThermo Fisher Scientific Earns Top Score for LGBTQ+ Workplace Equality for Seventh Cons..
PR
01/26Barclays Reinstates Thermo Fisher Scientific at Overweight with $700 Price Target
MT
01/21THERMO FISHER SCIENTIFIC INC. : Regulation FD Disclosure (form 8-K)
AQ
01/19Oncocyte Shares Drop 11% After Marketing Deal With Thermo Fisher
DJ
01/18OncoCyte Strikes Deal with Thermo Fisher to Expand Access to Precision Oncology
MT
01/18Oncocyte Announces Development and Co-Marketing Agreement with Thermo Fisher Scientific..
CI
01/11Thermo Fisher Scientific Exec Says Pricing Is Going To Be Higher In 2022 Than In Past Y..
RE
01/11Thermo fisher scientific exec says pricing is going to be higher in 2022 than in past y..
RE
01/11Thermo fisher scientific exec says demand for vaccines will be relevant at least into 2..
RE
01/10SomaLogic Hires Adam Taich as Chief Business Officer
MT
More news
Analyst Recommendations on THERMO FISHER SCIENTIFIC
More recommendations
Financials (USD)
Sales 2021 37 627 M - -
Net income 2021 7 855 M - -
Net Debt 2021 25 663 M - -
P/E ratio 2021 28,1x
Yield 2021 0,18%
Capitalization 218 B 218 B -
EV / Sales 2021 6,48x
EV / Sales 2022 5,84x
Nbr of Employees 80 000
Free-Float -
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 23
Last Close Price 553,74 $
Average target price 683,95 $
Spread / Average Target 23,5%
EPS Revisions
Managers and Directors
Marc N. Casper Chairman, President & Chief Executive Officer
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Alan B. Sachs Chief Medical Officer
Karen E. Nelson Chief Scientific Officer
Sector and Competitors